Teza Capital Management LLC Altimmune, Inc. Transaction History
Teza Capital Management LLC
- $809 Million
- Q2 2024
A detailed history of Teza Capital Management LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 12,370 shares of ALT stock, worth $77,065. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,370
Previous 12,326
0.36%
Holding current value
$77,065
Previous $125,000
34.4%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ALT
# of Institutions
192Shares Held
42.2MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$33.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$30.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$24.4 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.22MShares$20.1 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$17.1 Million2.23% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $305M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...